Michael T. Sapko, Michael Manyak, Riccardo Panicucci, & Jonathan C. Javitt. (2024). NRX-101 (D-Cycloserine + Lurasidone) Is Active against Drug-Resistant Urinary Pathogens In Vitro. MDPI AG.
Chicago Style (17th ed.) CitationMichael T. Sapko, Michael Manyak, Riccardo Panicucci, and Jonathan C. Javitt. NRX-101 (D-Cycloserine + Lurasidone) Is Active Against Drug-Resistant Urinary Pathogens In Vitro. MDPI AG, 2024.
MLA (9th ed.) CitationMichael T. Sapko, et al. NRX-101 (D-Cycloserine + Lurasidone) Is Active Against Drug-Resistant Urinary Pathogens In Vitro. MDPI AG, 2024.
Warning: These citations may not always be 100% accurate.